CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 364 enrolled
Drug / intervention
nailfold capillaroscopydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02801812
NCT02801812N/ACompleted

An Observational Multicenter International Case-control Study for the Assessment of Nailfold Capillary Abnormalities in Patients with Systemic Lupus Erythematosus

ASST Gaetano Pini-CTO·observational·Posted Jun 16, 2016·Updated Mar 21, 2025

In Brief

An observational study evaluating nailfold capillaroscopy for Systemic Lupus Erythematosus. Completed, enrolled 364 participants.

Detailed Summary

The purpose of this study is to investigate the role of nailfold capillaroscopy in the assessment of patients with Systemic Lupus Erythematosus (SLE). Primary endpoint: \- To compare the frequency of major capillaroscopic abnormalities in patients with SLE and healthy controls. Secondary endpoints: * To compare the frequency of major capillaroscopic abnormalities in patients with active and non-active SLE / active SLE and healthy controls / non-active SLE and healthy controls. * To study the association of different capillaroscopic parameters and the status of subjects (SLE / active SLE / non-active SLE / healthy controls).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 16, 2016
Enrollment StartJan 1, 2016
Primary CompletionDec 1, 2018
Study CompletionFeb 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 10.0 years ago

Interventions

nailfold capillaroscopydevice

Detection by nailfold capillaroscopy of capillary abnormalities in patients with Systemic Lupus Erythematosus and comparison with healthy controls at enrolment